These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 12014699

  • 1. Mechanisms of bone loss and gain in untreated and treated osteoporosis.
    Compston J.
    Endocrine; 2002 Feb; 17(1):21-7. PubMed ID: 12014699
    [No Abstract] [Full Text] [Related]

  • 2. Exploiting and bypassing the bone remodeling cycle to optimize the treatment of osteoporosis.
    Dempster DW.
    J Bone Miner Res; 1997 Aug; 12(8):1152-4. PubMed ID: 9258744
    [No Abstract] [Full Text] [Related]

  • 3. Effects of different regimens of sodium fluoride treatment for osteoporosis on the structure, remodeling and mineralization of bone.
    Balena R, Kleerekoper M, Foldes JA, Shih MS, Rao DS, Schober HC, Parfitt AM.
    Osteoporos Int; 1998 Aug; 8(5):428-35. PubMed ID: 9850350
    [Abstract] [Full Text] [Related]

  • 4. Prolonged treatments with antiresorptive agents and PTH have different effects on bone strength and the degree of mineralization in old estrogen-deficient osteoporotic rats.
    Cheng Z, Yao W, Zimmermann EA, Busse C, Ritchie RO, Lane NE.
    J Bone Miner Res; 2009 Feb; 24(2):209-20. PubMed ID: 18847326
    [Abstract] [Full Text] [Related]

  • 5. Effect of sodium fluoride, calcium, phosphate, and vitamin D2 on trabecular bone balance and remodeling in osteoporotics.
    Eriksen EF, Mosekilde L, Melsen F.
    Bone; 1985 Feb; 6(5):381-9. PubMed ID: 3879454
    [No Abstract] [Full Text] [Related]

  • 6. [Diagnostic imaging of treatment in osteoporosis: PTH].
    Ito M.
    Clin Calcium; 2011 Jul; 21(7):1067-73. PubMed ID: 21719988
    [Abstract] [Full Text] [Related]

  • 7. The therapeutic use of bisphosphonates.
    Compston JE.
    BMJ; 1994 Sep 17; 309(6956):711-5. PubMed ID: 7950525
    [No Abstract] [Full Text] [Related]

  • 8. New treatments for osteoporosis.
    Lancet; 1990 May 05; 335(8697):1065-6. PubMed ID: 1970372
    [No Abstract] [Full Text] [Related]

  • 9. Treatment of osteoporosis with sodium fluoride or parathyroid hormone.
    Riggs BL.
    Am J Med; 1991 Nov 25; 91(5B):37S-41S. PubMed ID: 1750415
    [No Abstract] [Full Text] [Related]

  • 10. Small bone-building fragments of parathyroid hormone: new therapeutic agents for osteoporosis.
    Whitfield JF, Morley P.
    Trends Pharmacol Sci; 1995 Nov 25; 16(11):382-6. PubMed ID: 8578607
    [Abstract] [Full Text] [Related]

  • 11. [Parathyroid and bone. Effect of parathyroid hormone on bone quality].
    Ito M.
    Clin Calcium; 2007 Dec 25; 17(12):1858-64. PubMed ID: 18057661
    [Abstract] [Full Text] [Related]

  • 12. Recombinant parathyroid hormone in the management of osteoporosis.
    Compston J.
    Calcif Tissue Int; 2005 Aug 25; 77(2):65-71. PubMed ID: 16059774
    [No Abstract] [Full Text] [Related]

  • 13. [Assessment of bone quality. Bone quality and osteoporosis treatment].
    Mashiba T.
    Clin Calcium; 2008 Mar 25; 18(3):300-7. PubMed ID: 18310816
    [Abstract] [Full Text] [Related]

  • 14. Efficacy data on teriparatide (parathyroid hormone) in patients with postmenopausal osteoporosis.
    Debiais F.
    Joint Bone Spine; 2003 Dec 25; 70(6):465-70. PubMed ID: 14667554
    [Abstract] [Full Text] [Related]

  • 15. Treatment of osteoporosis: role of bone-forming agents.
    Reginster JY, Halkin V, Henrotin Y, Gosset C.
    Osteoporos Int; 1999 Dec 25; 9 Suppl 2():S91-6. PubMed ID: 10525731
    [No Abstract] [Full Text] [Related]

  • 16. Sustained-release sodium fluoride in the management of established postmenopausal osteoporosis.
    Pak CY, Sakhaee K, Rubin CD, Zerwekh JE.
    Am J Med Sci; 1997 Jan 25; 313(1):23-32. PubMed ID: 9001163
    [No Abstract] [Full Text] [Related]

  • 17. Parathyroid hormone in the treatment of involutional osteoporosis: back to the future.
    Reginster JY, Taquet AN, Fraikin G, Gosset C, Zegels B.
    Osteoporos Int; 1997 Jan 25; 7 Suppl 3():S163-8. PubMed ID: 9536325
    [No Abstract] [Full Text] [Related]

  • 18. [Loss of trabecular bone strength and bone quality after 5 years of fluoride therapy for osteoporosis].
    Søgaard CH, Mosekilde L, Richards A, Mosekilde L.
    Ugeskr Laeger; 1995 Apr 03; 157(14):2004-8. PubMed ID: 7740640
    [Abstract] [Full Text] [Related]

  • 19. [Antiresorptive therapy for osteoporosis and bone quality].
    Kishimoto H.
    Clin Calcium; 2005 Jun 03; 15(6):1007-11. PubMed ID: 15930715
    [Abstract] [Full Text] [Related]

  • 20. New anabolic agents in the treatment of osteoporosis.
    Hough S.
    S Afr Med J; 2003 Oct 03; 93(10):754-6. PubMed ID: 14652963
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.